Tel: 1-631-626-9181 (USA)   44-207-097-1828 (Europe)
  Email:

Panoply™ Human MEF2A Knockdown Stable Cell Line

Cat.No.
CSC-DC009383
Description
Creative Biogene's Knockdown Cell Lines are target specific shRNA lentivirus transduced cells. The percent knockdown levels range from 75-99% depending on the gene, as evaluated by RT-PCR. Cells are rigorously qualified and mycoplasma free.
Growth Properties
Adherent
Host Cell
HEK293 (Hela and other cell types are also available)
Morphology
Epithelial
Quality Control
Negative for bacteria, yeast, fungi and mycoplasma.
Shipping
Dry Ice
Size/Form
2 × 10^6 cells / vial
Species
Human
Storage
Liquid Nitrogen
Gene Information
Gene Symbol
MEF2A
Synonyms
MEF2A; myocyte enhancer factor 2A; myocyte-specific enhancer factor 2A; serum response factor-like protein 1; MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A); mef2; ADCAD1; RSRFC4; RSRFC9;
Gene ID
mRNA Refseq
BC013437
Function
RNA polymerase II regulatory region sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription factor binding; SMAD binding; activating transcription factor binding; chromatin binding; histone acetyltransferase binding; histone deacetylase binding; protein binding; contributes_to protein binding; protein heterodimerization activity; protein kinase binding; sequence-specific DNA binding; sequence-specific DNA binding RNA polymerase II transcription factor activity; sequence-specific DNA binding transcription factor activity; sequence-specific distal enhancer binding RNA polymerase II transcription factor activity;
Pathway
Activated TLR4 signalling, organism-specific biosystem; Adipogenesis, organism-specific biosystem; CDO in myogenesis, organism-specific biosystem; Developmental Biology, organism-specific biosystem; ERK/MAPK targets, organism-specific biosystem; Energy Metabolism, organism-specific biosystem; Immune System, organism-specific biosystem;

Quick Inquiry

   Please input "biogene" as verification code.